Resistance of Mycobacterium tuberculosis to indole 4-carboxamides occurs through alterations in drug metabolism and tryptophan biosynthesis
暂无分享,去创建一个
T. Ioerger | P. Wyatt | S. Green | C. Barry | H. Boshoff | Peter C. Ray | Michael B. Goodwin | M. D. Libardo | Sangmi Oh | S. Thompson | C. Duncombe
[1] R. Chaisson,et al. Diagnostic accuracy of plasma kynurenine/tryptophan ratio, measured by enzyme-linked immunosorbent assay, for pulmonary tuberculosis. , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[2] Adam J. Schaenzer,et al. Antibiotic Resistance by Enzymatic Modification of Antibiotic Targets. , 2020, Trends in molecular medicine.
[3] Dean P. Jones,et al. Tryptophan catabolism reflects disease activity in human tuberculosis. , 2020, JCI insight.
[4] C. Barry,et al. Current and future treatments for tuberculosis , 2020, BMJ.
[5] S. Schreiber,et al. Allosteric inhibitors of Mycobacterium tuberculosis tryptophan synthase , 2020, Protein science : a publication of the Protein Society.
[6] Vinayak Singh,et al. Drug-resistance in Mycobacterium tuberculosis: where we stand. , 2019, MedChemComm.
[7] M. Zimmerman,et al. Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in Mycobacterium tuberculosis , 2019, mBio.
[8] A. Garza-Garcia,et al. Flexible nitrogen utilisation by the metabolic generalist pathogen Mycobacterium tuberculosis , 2019, eLife.
[9] J. Sacchettini,et al. Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition , 2019, Science.
[10] J. Lott,et al. Mechanism of Fluorinated Anthranilate-Induced Growth Inhibition in Mycobacterium tuberculosis. , 2019, ACS infectious diseases.
[11] C. Barry,et al. The present state of the tuberculosis drug development pipeline , 2018, Current opinion in pharmacology.
[12] J. Micklefield,et al. De novo Biosynthesis of “Non‐Natural” Thaxtomin Phytotoxins , 2018, Angewandte Chemie.
[13] N. Loman,et al. Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface , 2017, Scientific Reports.
[14] Frances H Arnold,et al. Unlocking Reactivity of TrpB: A General Biocatalytic Platform for Synthesis of Tryptophan Analogues , 2017, Journal of the American Chemical Society.
[15] S. Schreiber,et al. A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase. , 2017, Nature chemical biology.
[16] Thomas R. Ioerger,et al. Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis. , 2017, ACS infectious diseases.
[17] A. Steyn,et al. Turning the respiratory flexibility of Mycobacterium tuberculosis against itself , 2016, Nature Communications.
[18] A. Earl,et al. Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis Inhibitors. , 2016, Cell chemical biology.
[19] Yu‐ming M. Huang,et al. Visualizing the tunnel in tryptophan synthase with crystallography: Insights into a selective filter for accommodating indole and rejecting water. , 2016, Biochimica et biophysica acta.
[20] F. Arnold,et al. Directed evolution of the tryptophan synthase β-subunit for stand-alone function recapitulates allosteric activation , 2015, Proceedings of the National Academy of Sciences.
[21] E. Baker,et al. Structure and inhibition of subunit I of the anthranilate synthase complex of Mycobacterium tuberculosis and expression of the active complex. , 2015, Acta crystallographica. Section D, Biological crystallography.
[22] V. Mizrahi,et al. The complex mechanism of antimycobacterial action of 5-fluorouracil. , 2015, Chemistry & biology.
[23] S. Gamage,et al. Repurposing the Chemical Scaffold of the Anti‐Arthritic Drug Lobenzarit to Target Tryptophan Biosynthesis in Mycobacterium tuberculosis , 2014, Chembiochem : a European journal of chemical biology.
[24] Thomas R. Ioerger,et al. Tryptophan Biosynthesis Protects Mycobacteria from CD4 T-Cell-Mediated Killing , 2013, Cell.
[25] E. M. Bulloch,et al. The substrate capture mechanism of Mycobacterium tuberculosis anthranilate phosphoribosyltransferase provides a mode for inhibition. , 2013, Biochemistry.
[26] M. Dunn. Allosteric regulation of substrate channeling and catalysis in the tryptophan synthase bienzyme complex. , 2012, Archives of biochemistry and biophysics.
[27] A. Aiyar,et al. Inhibition of Indoleamine 2,3-Dioxygenase Activity by Levo-1-Methyl Tryptophan Blocks Gamma Interferon-Induced Chlamydia trachomatis Persistence in Human Epithelial Cells , 2011, Infection and Immunity.
[28] Jason T. Huff,et al. Taking phage integration to the next level as a genetic tool for mycobacteria. , 2010, Gene.
[29] S. Fortune,et al. Variation among Genome Sequences of H37Rv Strains of Mycobacterium tuberculosis from Multiple Laboratories , 2010, Journal of bacteriology.
[30] L. A. Basso,et al. Steady-state kinetics of indole-3-glycerol phosphate synthase from Mycobacterium tuberculosis. , 2009, Archives of biochemistry and biophysics.
[31] H. Shen,et al. Characterization of the putative tryptophan synthase beta-subunit from Mycobacterium tuberculosis. , 2009, Acta biochimica et biophysica Sinica.
[32] P. Schultz,et al. A promiscuous aminoacyl-tRNA synthetase that incorporates cysteine, methionine, and alanine homologs into proteins. , 2008, Bioorganic & medicinal chemistry letters.
[33] A. Zaha,et al. Identification of Mutations Related to Streptomycin Resistance in Clinical Isolates of Mycobacterium tuberculosis and Possible Involvement of Efflux Mechanism , 2008, Antimicrobial Agents and Chemotherapy.
[34] C. Yanofsky,et al. Evolution of bacterial trp operons and their regulation. , 2008, Current opinion in microbiology.
[35] Sabine Ehrt,et al. Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor , 2005, Nucleic acids research.
[36] N. Budisa,et al. Designing novel spectral classes of proteins with a tryptophan-expanded genetic code , 2004, Biological chemistry.
[37] T. Parish,et al. Control of the acetamidase gene of Mycobacterium smegmatis by multiple regulators. , 2003, FEMS microbiology letters.
[38] R. Huber,et al. Global replacement of tryptophan with aminotryptophans generates non-invasive protein-based optical pH sensors. , 2002, Angewandte Chemie.
[39] G. Besra,et al. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis , 2002, Molecular microbiology.
[40] R L Jernigan,et al. Cooperative fluctuations and subunit communication in tryptophan synthase. , 1999, Biochemistry.
[41] E. Werner,et al. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. , 1997, Clinical chemistry.
[42] R. Abeles,et al. Inhibition of tryptophan synthase by (1-fluorovinyl)glycine. , 1993, Biochemistry.
[43] W. Jacobs,et al. New use of BCG for recombinant vaccines , 1991, Nature.
[44] D. Pierson,et al. The regulation of tryptophan biosynthesis in Pseudomonas aeruginosa , 1973, Molecular and General Genetics MGG.
[45] C. Sassetti,et al. Mycobacterial recombineering. , 2015, Methods in molecular biology.
[46] L. Gabbasova,et al. Global tuberculosis report (2014) , 2014 .